Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia

British Journal of Haematology

Volumn 153, Issue 2, 2011, Pages 179-190

  Foroni, Letizia ^a   Wilson, Gill ^b   Gerrard, Gareth ^a   Mason, Joanne ^c   Grimwade, David ^d   White, Helen E ^e   de Castro, David Gonzalez ^f   Austin, Stephen ^g   Awan, Abida ^h   Burt, Emma ⁱ   Clench, Tim ^j   Farruggia, Joanna ^k   Hancock, Jeremy ^l   Irvine, Alexandra E ^m   Kizilors, Aytug ⁿ   Langabeer, Stephen ^o   Milner, Benedict J ^p   Nickless, Guillermina ^q   Schuh, Anna ^r   Sproul, Anne ^s   Wang, Lihui ^t   Wickham, Caroline ^u   Cross, Nicholas C P ^e,v   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e National Genetics Reference Laboratory Wessex   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^h MANCHESTER ROYAL INFIRMARY   (United Kingdom)

ⁱ BARTS HEALTH NHS TRUST   (United Kingdom)

^j BRISTOL ROYAL INFIRMARY   (United Kingdom)

^k DERRIFORD HOSPITAL   (United Kingdom)

^l SOUTHMEAD HOSPITAL   (United Kingdom)

^m Centre for Cancer Research and Cell Biology   (United Kingdom)

ⁿ KING S COLLEGE HOSPITAL   (United Kingdom)

^o ST JAMES S HOSPITAL   (Ireland)

^p ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^q GUY S HOSPITAL   (United Kingdom)

^r JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^s WESTERN GENERAL HOSPITAL   (United Kingdom)

^t ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^u ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^v UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

more..

Author keywords

ABL1; BCR; Chronic myeloid leukaemia; Guidelines; Real time PCR

Indexed keywords

BCR ABL PROTEIN; DASATINIB; IMATINIB; NILOTINIB;

ARTICLE; CHRONIC MYELOID LEUKEMIA; FUSION GENE; HUMAN; IRELAND; LEUKEMIA REMISSION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; UNITED KINGDOM;

FUSION PROTEINS, BCR-ABL; GREAT BRITAIN; HUMANS; IRELAND; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MOLECULAR BIOLOGY; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; PROTEIN KINASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SOCIETIES, MEDICAL;

EID: 79953077414     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08603.x     Document Type: Article

References (31)

1. Baccarani, M., Cortes, J., Pane, F., Niederwieser, D., Saglio, G., Apperley, J., Cervantes, F., Deininger, M., Gratwohl, A., Guilhot, F., Hochhaus, A., Horowitz, M., Hughes, T., Kantarjian, H., Larson, R., Radich, J., Simonsson, B., Silver, R.T., Goldman, J. & Hehlmann, R.; European LeukemiaNet (2009). Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. Journal of Clinical Oncology, 27, 6041-6051.
2. Beillard, E., Pallisgaard, N., van der Velden, V.H., Bi, W., Dee, R., van der Schoot, E., Delabesse, E., Macintyre, E., Gottardi, E., Saglio, G., Watzinger, F., Lion, T., van Dongen, J.J., Hokland, P. & Gabert, J. (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia, 17, 2474-2486.
3. Branford, S. & Hughes, T. (2006) Diagnosis and monitoring of chronic myeloid leukemia by qualitative and quantitative RT-PCR. Methods in Molecular Medicine, 125, 69-92.
4. Branford, S., Cross, N.C., Hochhaus, A., Radich, J., Saglio, G., Kaeda, J., Goldman, J. & Hughes, T. (2006) Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia, 20, 1925-1930.
5. Branford, S., Fletcher, L., Cross, N.C., Muller, M.C., Hochhaus, A., Kim, D.W., Radich, J.P., Saglio, G., Pane, F., Kamel-Reid, S., Wang, Y.L., Press, R.D., Lynch, K., Rudzki, Z., Goldman, J.M. & Hughes, T. (2008) Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood, 112, 3330-3338.
6. Burmeister, T. & Reinhardt, R. (2008) A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts. Leukemia Research, 32, 579-585.
7. Bustin, S.A. (2010) Developments in real-time PCR research and molecular diagnostics. Expert Review of Molecular Diagnostics, 10, 713-715.
8. Cross, N.C. (2009) Standardisation of molecular monitoring for chronic myeloid leukaemia. Best Practice and Research. Clinical Haematology, 22, 355-365.
9. Cross, N.C., Feng, L., Chase, A., Bungey, J., Hughes, T.P. & Goldman, J.M. (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929-1936.
10. Cross, N.C., Melo, J.V., Feng, L. & Goldman, J.M. (1994) An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia, 8, 186-189.
11. Dhut, S., Gibbons, B., Chaplin, T. & Young, B.D. (1991) Establishment of a lymphoblastoid cell line, SD-1, expressing the p190 bcr-abl chimaeric protein. Leukemia, 5, 49-55.
12. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. & Lydon, N.B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Medicine, 2, 561-566.
13. Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., Ohno-Jones, S. & Sawyers, C.L. (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine, 344, 1031-1037.
14. Foroni, L., Gerrard, G., Nna, E., Khorashad, J.S., Stevens, D., Swale, B., Milojkovic, D., Reid, A., Goldman, J. & Marin, D. (2009) Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. American Journal of Hematology, 84, 517-522.
15. Gabert, J., Beillard, E., van der Velden, V.H., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J.M., Cavé, H., Pane, F., Aerts, J.L., De Micheli, D., Thirion, X., Pradel, V., González, M., Viehmann, S., Malec, M., Saglio, G. & van Dongen, J.J. (2003) Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia, 17, 2318-2357.
16. Gerrard, G., Mudge, K., Stewart, R., Foskett, P., Stevens, D., Khorashad, J.S., Szydlo, R., Rezvani, K., Marin, D., Reid, A., Apperley, J., Goldman, J. Foroni, L. (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1 associated haematologicl malignancies. American Journal of Hematology, 86, 313-315
17. Hochhaus, A., Reiter, A., Skladny, H., Melo, J.V., Sick, C., Berger, U., Guo, J.Q., Arlinghaus, R.B., Hehlmann, R., Goldman, J.M. & Cross, N.C. (1996) A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood, 88, 2236-2240.
18. Hughes, T., Deininger, M., Hochhaus, A., Branford, S., Radich, J., Kaeda, J., Baccarani, M., Cortes, J., Cross, N.C., Druker, B.J., Gabert, J., Grimwade, D., Hehlmann, R., Kamel-Reid, S., Lipton, J.H., Longtine, J., Martinelli, G., Saglio, G., Soverini, S., Stock, W. & Goldman, J.M. (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood, 108, 28-37.
19. Kantarjian, H., Shah, N.P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., Nakamae, H., Huguet, F., Boqué, C., Chuah, C., Bleickardt, E., Bradley-Garelik, M.B., Zhu, C., Szatrowski, T., Shapiro, D. & Baccarani, M. (2010) Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. New England Journal of Medicine, 362, 2260-2270.
20. Kawasaki, E.S., Clark, S.S., Coyne, M.Y., Smith, S.D., Champlin, R., Witte, O.N. & McCormick, F.P. (1988) Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proceedingsof the National Academia of Science, U S A, 85, 5698-5702.
21. Lozzio, B.B. & Lozzio, C.B. (1977) Properties of the K562 cell line derived from a patient with chronic myeloid leukemia. International Journal of Cancer, 19, 136.
22. Melo, J.V. (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood, 88, 2375-2384.
23. Melo, J.V. & Chuah, C. (2007) Resistance to imatinib mesylate in chronic myeloid leukaemia. Cancer Letters, 249, 121-132.
24. Nowell, P.C. & Hungerford, D.A. (1960) Chromosome studies on normal and leukemic human leukocytes. Journal of National Cancer Institute, 25, 85-109.
25. O'Hare, T., Walters, D.K., Stoffregen, E.P., Jia, T., Manley, P.W., Mestan, J., Cowan-Jacob, S.W., Lee, F.Y., Heinrich, M.C., Deininger, M.W. & Druker, B.J. (2005) In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Research, 65, 4500-4505.
26. Rowley, J.D. (1973) Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. Annals of Genetics, 16, 109-112.
27. Saglio, G., Kim, D.W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R.E., Hochhaus, A., Hughes, T.P., Gallagher, N., Hoenekopp, A., Dong, M., Haque, A., Larson, R.A. & Kantarjian, H.M.; ENESTnd Investigators (2010) Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. New England Journal of Medicine, 362, 2251-2259.
28. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature, 315, 550-554.
29. van der Velden, V.H., Boeckx, N., Gonzalez, M., Malec, M., Barbany, G., Lion, T., Gottardi, E., Pallisgaard, N., Beillard, E., Hop, W.C., Hoogeveen, P.G., Gabert, J. & van Dongen, J.J.; Europe Against Cancer Program (2004) Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - a study within the Europe Against Cancer Program. Leukemia, 18, 884-886.
30. Westbrook, C.A., Hooberman, A.L., Spino, C., Dodge, R.K., Larson, R.A., Davey, F., Wurster-Hill, D.H., Sobol, R.E., Schiffer, C. & Bloomfield, C.D. (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood, 80, 2983-2990.
31. White, H.E., Matejtschuk, P., Rigsby, P., Gabert, J., Lin, F., Wang, Y.L., Branford, S., Muller, M.C., Beaufils, N., Beillard, E., Colomer, D., Dvorakova, D., Ehrencrona, H., Goh, H.G., El Housni, H., Jones, D., Kairisto, V., Kamel-Reid, S., Kim, D.W., Langabeer, S., Ma, E.S., Press, R.D., Romeo, G., Wang, L., Zoi, K., Hughes, T., Saglio, G., Hochhaus, A., Goldman, J.M., Metcalfe, P. & Cross, N.C. (2010) Establishment of the 1st World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood, 116, 111-117.